Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 1, 1997, Pages 117-121

  Milano, Salvatore ^a   Arcoleo, Francesco ^a   D'Agostino, Pietro ^a   Cillari, Enrico ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b Institute of General Pathology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEXAMETHASONE SODIUM PHOSPHATE; DOXYCYCLINE; INTERLEUKIN 1ALPHA; LIPOPOLYSACCHARIDE; NITRATE; NITRIC OXIDE SYNTHASE; NITRITE; TETRACYCLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME INDUCTION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LETHALITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0031028175     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.1.117     Document Type: Article

References (41)

1. Alexander, H. R., G. M. Doherty, C. M. Buresh, D. J. Venzon, and J. A. Norton. 1991. A recombinant human receptor antagonist interleukin 1 improves survival after lethal endotoxemia in mice. J. Exp. Med. 173:1029-1032.
2. Alon, R., L. Cahalon, R. Hershkoviz, D. Elbaz, B. Reizis, D. Wallach, S. K. Akiyama, K. M. Yamada, and O. Lider. 1994. TNF binds to the N-terminal domain of fibronectin and augments the β1-integrin-mediated adhesion of CD4+ T lymphocytes to the glycoprotein. J. Immunol. 152:1304-1313.
3. Bauss, F., W. Droge, and D. N. Mannel. 1987. Tumor necrosis factor mediates endotoxic effects in mice. Infect. Immun. 55:1622-1625.
4. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachetin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869-871.
5. Bone, R. C. 1991. The pathogenesis of sepsis. Ann. Intern. Med. 115:457-467.
6. Breedveld, F. C., B. A. C. Dijkmans, and H. Mattie. 1990. Minocycline treatment for rheumatoid arthritis: an open dose finding study. J. Rheumatol. 17:43-46.
7. Cillari, E., F. Arcoleo, M. Dieli, R. D'Agostino, G. Gromo, F. Leoni, and S. Milano. 1994. The macrophage-activating tetrapeptide tuftsin induces nitric oxide synthesis and stimulates murine macrophages to kill Leishmania parasites in vitro. Infect. Immun. 62:2649-2652.
8. Cunha, F. Q., J. Assreuy, D. W. Moss, D. Rees, L. M. C. Leal, S. Moncada, M. Carrier, C. A. O'Donnell, and F. Y. Liew. 1994. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxemia: role of TNF-α and IL-1β. Immunology 81:211-215.
9. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2412.
10. Dornand, J., M. Bouaboula, A. D. D'Angeac, J. Favero, D. Shore, and P. Casellas. 1992. Contrasting effects of the protein kinase C inhibitor staurosporine on the interleukin 1 and phorbol ester activation pathways in the EL4-6.1 thymoma cell line. J. Cell. Physiol. 151:71-77.
11. Eierman, D. F., C. E. Johnson, and J. S. Haskill. 1989. Human monocyte inflammatory mediator gene expression is selectively regulated by adherence substrates. J. Immunol. 142:1970-1976.
12. Gilat, D., L. Cahalon, R. Hershkoviz, and O. Lider. 1996. Interplay of T cells and cytokines in the context of enzymatically modified extracellular matrix. Immunol. Today 17:16-20.
13. Glauser, M. P., G. Zanetti, J. D. Baumgartner, and J. Cohen. 1991. Septic shock: pathogenesis. Lancet 338:732-736.
14. Golub, L. M., N. S. Ramamurthy, T. F. McNamara, B. Gomes, M. Wolff, A. Casino, A. Kapoor, J. Zambon, S. G. Ciancio, M. Schneir, and H. Perry. 1984. Tetracyclines inhibit tissue collagenase activity: a new mechanism in the treatment of periodontal disease. J. Periodont. Res. 19:651-655.
15. Golub, L. M., T. F. McNamara, G. D'Angelo, R. A. Greenwald, and N. S. Ramamurthy. 1987. A non-antibacterial chemically modified tetracycline inhibits mammalian collagenase activity. J. Dent. Res. 66:1310-1314.
16. Golub, L. M., N. S. Ramamurthy, and T. F. McNamara. 1991. Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit. Rev. Oral Biol. Med. 2:297-322.
17. Keeting, P. E., L. Rifas, S. A. Harris, D. S. Colvard, T. C. Spelsberg, W. A. Peck, and B. L. Riggs. 1991. Evidence for interleukin-1 beta production by cultured normal human osteoblast-like cells. J. Bone Min. Res. 6:827-833.
18. Lamas, S., P. A. Marsden, G. K. Li, P. Tempst, and T. Michel. 1992. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc. Natl. Acad. Sci. USA 8:6348-6352.
19. Liew, F. Y., and F. E. G. Cox. 1991. Nonspecific defence mechanism: the role of nitric oxide. Immunol. Today 3:17-21.
20. Marcinkiewicz, J., A. Grabowska, and B. Chain. 1995. Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages. Eur. J. Immunol. 25:947-951.
21. Mathison, J. C., E. Wolfson, and R. J. Ulevitch. 1988. Participation of tumor necrosis factor in the mediation of gram-negative bacterial lipopolysaccharide-induced injury in rabbits. J. Clin. Invest. 81:1925-1937.
22. Moncada, S., and A. Higgs. 1993. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:2002-2012.
23. Nair, S. P., S. Meghji, M. Wilson, K. Reddi, P. White, and B. Henderson. 1996. Bacterially induced bone destruction: mechanisms and misconceptions. Infect. Immun. 64:2371-2380.
24. Nava, E., R. M. J. Palmer, and S. Moncada. 1991. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet 338:1555-1557.
25. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-3064.
26. O'Neill, L. A. J. 1995. Interleukin-1 signal transduction. Int. J. Clin. Lab. Res. 25:169-177.
27. Palmer, R. M. J., D. D. Asshton, and S. Moncada. 1988. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664-666.
28. Petros, A., D. Bennett, and P. Vallance. 1991. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338:1557-1558.
29. Ramamurthy, N. S., A. T. Vernillo, R. A. Greenwald, H.-M. Lee, T. Sorsa, L. M. Golub, and B. R. Rifkin. 1993. Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase. J. Bone Min. Res. 10:1247-1253.
30. Rogy, M. A., T. Auffenberg, N. J. Espat, R. Philip, D. Remick, G. K. Wollenberg, E. M. Copeland III, and L. L. Moldawer. 1995. Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses. J. Exp. Med. 181:2289-2293.
31. Rifkin, B. R., A. T. Vernillo, and L. M. Golub. 1993. Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically-modified analogs. J. Periodontal Res. 64:819-827.
32. Resales, C., and R. L. Juliano. 1995. Signal transduction by cell adhesion receptors in leukocytes. Leukocyte Biol. 57:189-198.
33. 2+-independent nitric oxide synthase. FEBS Lett. 291:145-149.
34. Shapira, L., W. A. Soskolne, Y. Houri, V. Barak, A. Halabi, and A. Stabholz. 1996. Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion. Infect. Immun. 64:825-828.
35. Van Zee, K. J., T. Kohno, E. Fisher, C. S. Rock, L. L. Moldawer, and S. F. Lowry. 1992. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc. Natl. Acad. Sci. USA 89:4845-4849.
36. Xie, Q.-W., H. J. Cho, J. Calycay, R. A. Mumford, K. M. Swiderek, T. D. Lee, A. Ding, T. Troso, and C. Nathan. 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225-228.
37. Waage, A., and T. Espevik. 1988. Interleukin 1 potentiates the lethal effect of tumor necrosis factor/cachectin in mice. J. Exp. Med. 167:1987-1992.
38. Webster, G. F., S. M. Toso, and L. Hegemann. 1994. Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin. Involvement of protein kinase C. Arch. Dermatol. 130:748-752.
39. Wright, S. D. 1991. Multiple receptors for endotoxin. Curr. Opin. Immunol. 3:83-90.
40. Wright, C. E., D. D. Ress, and S. Moncada. 1992. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res. 26:48-57.
41. Zanetti, G., D. Heumann, J. Gerain, J. Kolher, P. Abbet, C. Barras, R. Lukas, M. P. Glauser, and J. D. Baumgartner. 1992. Cytokine production after intravenous or peritoneal Gram-negative bacterial challenge in mice. J. Immunol. 148:1890-1897.